logo

For the Inventor, By the Inventor

Mississauga, Canada

Sumanas Rakhit

This inventor holds 17 USPTO granted patents. Top assignee: Allelix Biopharmaceuticals Inc.. Active years: 1996-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumanas Rakhit. Retrieved from https://idiyas.com/inventor/sumanas-rakhit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 86(Granted Patents)


Location History:

  • Misssissauga, CA (1999)
  • Mississauga, CA (1996 - 2000)

Company Filing History:

goldMedal17 out of 69 
 
Allelix Biopharmaceuticals Inc.
 patents

Years Active: 1996-2000

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6103715 - Dopamine receptor ligands (2000-08-15),
2. 5998462 - 5-alkyl indole compounds (1999-12-07),
3. 5998438 - 5-cyclo indole compounds (1999-12-07),
4. 5968478 - N- methyl piperazine compounds having dopamine receptor affinity (1999-10-19),
5. 5856510 - 5-alkenyl and 5-alkynyl indole compounds (1999-01-05),
6. 5849734 - Muscarinic receptor ligands (1998-12-15),
7. 5824676 - 5-HT2 receptor ligands (1998-10-20),
8. 5798350 - Dopamine receptor ligands (1998-08-25),
9. 5770742 - Thiophene-tryptamine derivatives (1998-06-23),
10. 5703072 - Bicyclic nonane and decane compounds having dopamine receptor affinity (1997-12-30),
11. 5700445 - N-methyl piperazine compounds having dopamine receptor affinity (1997-12-23),
12. 5674877 - Muscarinic receptor ligands (1997-10-07),
13. 5627194 - Anti-viral guanidino-substituted compounds (1997-05-06),
14. 5602124 - 5-HT2 receptor ligands (1997-02-11),
15. 5576314 - Bicyclic nonane and decane compounds having dopamine receptor affinity (1996-11-19),

Title: The Innovative Contributions of Sumanas Rakhit

Introduction

Sumanas Rakhit is a prominent inventor based in Mississauga, Canada, known for his significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 17 patents, Rakhit has made strides in developing compounds that target specific receptors in the human body, showcasing his expertise and innovative spirit.

Latest Patents

Among his latest patents, Rakhit has developed dopamine receptor ligands, which include D4 receptor-selective compounds. These compounds are described by a general formula that allows for the selection of various saturated or unsaturated rings. Additionally, he has worked on 5-cyclo indole compounds that are selective for a 5-HT1D-like receptor, featuring a general formula that includes non-aromatic carbocycles and heterocycles with specific heteroatoms.

Career Highlights

Rakhit has built a successful career at Allelix Biopharmaceuticals Inc., where he has been instrumental in advancing research and development in the biopharmaceutical sector. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications.

Collaborations

Throughout his career, Rakhit has collaborated with notable colleagues, including Ashok Tehim and Jian-Min Fu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…